Skip to main content
. 2016 Feb 5;6:20189. doi: 10.1038/srep20189

Figure 4. BKM-120 treatment blocks glioma growth and invasion in vivo.

Figure 4

To analyze the effects of BKM-120 in vivo, we injected U1242 cells intracranially in nude mice and treated them daily with 2 mg/kg and 20 mg/kg of BKM-120 by gavage. (A) Average of the the tumors perimeters measured at day 7, and corrected for the averages of the size of the tumors at day 4. (B) Tumor spread was examined using Vimentin and DAPI staining. Photographs illustrate tumor growth (low resolution, bar = 1 mm) and the tumor normal brain interface indicating the degree of invasion (high resolution, bar = 20 μm). One-way ANOVA was used for statistical analysis (**p < 0.01, ***p < 0.001).